C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.260
-0.030 (-1.31%)
Jul 25, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
Targeted Protein Degradation
20.76M
Log In
Log In
Log In
Log In
Upgrade
Targeted Protein Degradation Growth
-33.25%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018
United States
20.76M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-33.25%
Log In
Log In
Log In
Log In
Upgrade